Precision BioSciences, Inc. Forecast, price target & analysts
Precision BioSciences, Inc. Target price 2025 - Analyst rating & recommendation
Precision BioSciences, Inc. Classifications & Recommendation:
Precision BioSciences, Inc. Price Target
| Target Price | $21.93 |
| Price | $4.30 |
| Potential |
410.00%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Precision BioSciences, Inc. 2026 .
The average Precision BioSciences, Inc. target price is $21.93.
This is
410.00%
register free of charge
$31.50
632.56%
register free of charge
$13.13
205.35%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Precision BioSciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Precision BioSciences, Inc. stock has an average upside potential 2026 of
410.00%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 68.70 | 22.41 |
| 40.98% | 67.39% | |
| EBITDA Margin | -34.12% | -186.19% |
| 58.13% | 445.70% | |
| Net Margin | 10.44% | -291.69% |
| 108.29% | 2,894.85% |
6 Analysts have issued a sales forecast Precision BioSciences, Inc. 2025 . The average Precision BioSciences, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Precision BioSciences, Inc. EBITDA forecast 2025. The average Precision BioSciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Precision BioSciences, Inc. Analysts have issued a net profit forecast 2025. The average Precision BioSciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.04 | -6.19 |
| 106.52% | 695.19% | |
| P/E | negative | |
| EV/Sales | negative |
6 Analysts have issued a Precision BioSciences, Inc. forecast for earnings per share. The average Precision BioSciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Precision BioSciences, Inc....
Current Precision BioSciences, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 19 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 22 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 19 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 19 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 22 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
